|
|
||||||||
Ann Thorac Surg 2003;75:1086-1090
© 2003 The Society of Thoracic Surgeons
a Department of General and Thoracic Surgery, Justus-Liebig-University of Gießen, Gießen, Germany
Accepted for publication November 1, 2002.
* Address reprint requests to Dr Hoerbelt, Transplantation Biology Research Center, Massachusetts General Hospital, Bldg 149, 13th St, Charlestown, MA 02129, USA
e-mail: ruediger.hoerbelt{at}tbrc.mgh.harvard.edu
BACKGROUND: Mediastinal tumors show a wide variability, and therefore, a standardized diagnostic and therapeutic workup is instrumental. We subdivided mediastinal tumors into nonlymphatic mediastinal tumors (NLMTs), most of which require surgical resection without need of preoperative histology, and mediastinal lymphadenopathy (MLA), requiring surgical biopsy for exact histologic classification. We investigated the accuracy of noninvasive diagnostic studies distinguishing between the two groups of MLA and NLMT.
METHODS: A retrospective analysis was performed on patients who had previously undergone surgery on mediastinal tumors. Their data were statistically analyzed (
2 test, logistic regression analysis), and the values of medical history, physical examination, laboratory tests, and computerized tomography scan discriminating between MLA and NLMT were assessed.
RESULTS: Out of 299 patients included in the study, 242 (80.9%) had MLA and 57 (19.1%) had NLMT. Sensitivity and specificity of noninvasive investigations for differentiation of MLA and NLMT were 98.2% and 86.0%, respectively. Whereas the prevalence of thoracic symptoms such as shortness of breath, cough, or chest pain was similar in both groups (MLA, 165 [69.3%]; NLMT, 41 [69.5%]; p = 0.98), systemic symptoms, including fever, night sweats, or weight loss (MLA, 110 [49.8%]; NLMT, 17 [29.3%]; p < 0.01), and signs of inflammation, such as c-reactive protein, erythrocyte sedimentation rate, and leukocytosis (MLA, 202 [85.6%]; NLMT, 34 [57.6%]; p < 0.001), were significantly more common in MLA.
CONCLUSIONS: Noninvasive diagnostic procedures, including medical history, physical examination, laboratory tests, and computerized tomographic scan, are highly sensitive in detecting MLAs that should undergo surgical biopsy. Our data suggest confirming all suspected NLMTs by fine needle aspiration (FNA) biopsy before surgery.
This article has been cited by other articles:
![]() |
P. R. Koduri The Diagnostic Approach to Mediastinal Masses Ann. Thorac. Surg., November 1, 2004; 78(5): 1888 - 1888. [Full Text] [PDF] |
||||
![]() |
R. Hoerbelt and W. Padberg Reply Ann. Thorac. Surg., November 1, 2004; 78(5): 1888 - 1888. [Full Text] [PDF] |
||||
![]() |
A. Sami Bayram, B. Ozdemir, F. Aydiner, and S. Gullulu Carcinosarcoma as a primary mediastinal tumor Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 11 - 13. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |